Our Story

When Dr. Samira Sadeghi and Dr. Mohammad Tavakkoli first met at the National University of Singapore in 2015, they shared more than just their doctoral studies; they shared a personal mission to transform cancer care. Having both experienced the loss of loved ones to the disease, they recognized that the future of oncology required a bridge between two distinct worlds: cancer biology and nanobiotechnology.

This fusion of expertise, fueled by a shared commitment to patient outcomes, is what led to the founding of OncoRevive in late 2023.